Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
KPC Pharmaceuticals Inc
600422KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China. Address: No.166 Keyi Road, Kunming, China, 650106
Analytics
Precio Objetivo de WallStreet
171.92 CNYRelación P/E
26.6949Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 600422
Análisis de dividendos 600422
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
33 %Tendencia del payout 600422
Valoración de la acción 600422
Finanzas 600422
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |